Therapy Links, Llc | |
80 Shallow Lake Cir, Allensville, KY 42204-9057 | |
(800) 898-1405 | |
(888) 898-8972 |
Full Name | Therapy Links, Llc |
---|---|
Type | Facility |
Speciality | Speech-language Pathologist |
Location | 80 Shallow Lake Cir, Allensville, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013206697 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Therapy Links, Llc 80 Shallow Lake Cir, Allensville, KY 42204-9057 Ph: (800) 898-1405 | Therapy Links, Llc 80 Shallow Lake Cir, Allensville, KY 42204-9057 Ph: (800) 898-1405 |
News Archive
ev3 Inc., a global endovascular device company, today reported financial results for its fiscal first quarter and updated financial guidance for 2010. ev3's net sales totaled $123.9 million in the first quarter of 2010 compared to $100.4 million in the same quarter of the prior year. Excluding $2.9 million of positive impact due to foreign currency exchange rates, net sales increased 21% versus the prior year quarter.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
Hospitals across the globe are becoming increasingly confident about their growth prospects for the year ahead despite rising costs and ongoing economic uncertainty, according to GE Capital's inaugural Hospital Sentiment Research – a report based on interviews with more than 380 senior hospital executives with responsibility for budget decisions over eight international markets.
Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.
› Verified 5 days ago
Gail Guarino Constantini, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 80 Shallow Lake Cir, Allensville, KY 42204 Phone: 800-898-1405 | |
Stephanie Jill Kimmelman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 80 Shallow Lake Cir, Allensville, KY 42204 Phone: 800-898-1405 |